PepGen Inc. (PEPG)

USD 1.1

(-12.75%)

Total Liabilities Summary of PepGen Inc.

  • PepGen Inc.'s latest annual total liabilities in 2023 was 34.63 Million USD , down -8.41% from previous year.
  • PepGen Inc.'s latest quarterly total liabilities in 2024 Q2 was 38.47 Million USD , up 37.39% from previous quarter.
  • PepGen Inc. reported annual total liabilities of 37.8 Million USD in 2022, up 258.48% from previous year.
  • PepGen Inc. reported annual total liabilities of 10.54 Million USD in 2021, up 1115.09% from previous year.
  • PepGen Inc. reported quarterly total liabilities of 28 Million USD for 2024 Q1, down -19.14% from previous quarter.
  • PepGen Inc. reported quarterly total liabilities of 36.19 Million USD for 2023 Q1, down -4.26% from previous quarter.

Annual Total Liabilities Chart of PepGen Inc. (2023 - 2019)

Historical Annual Total Liabilities of PepGen Inc. (2023 - 2019)

Year Total Liabilities Total Liabilities Growth
2023 34.63 Million USD -8.41%
2022 37.8 Million USD 258.48%
2021 10.54 Million USD 1115.09%
2020 868 Thousand USD 166.26%
2019 326 Thousand USD 0.0%

Peer Total Liabilities Comparison of PepGen Inc.

Name Total Liabilities Total Liabilities Difference
AbCellera Biologics Inc. 335.77 Million USD 89.686%
Alkermes plc 933.53 Million USD 96.29%
Agenus Inc. 462.29 Million USD 92.509%
Alnylam Pharmaceuticals, Inc. 4.05 Billion USD 99.145%
Aptorum Group Limited 5.25 Million USD -558.793%
Ardelyx, Inc. 130.76 Million USD 73.516%
Arrowhead Pharmaceuticals, Inc. 478.39 Million USD 92.761%
Bicycle Therapeutics plc 224.41 Million USD 84.568%
BioXcel Therapeutics, Inc. 130.21 Million USD 73.404%
ChromaDex Corporation 26.5 Million USD -30.644%
Chimerix, Inc. 19.74 Million USD -75.391%
Corbus Pharmaceuticals Holdings, Inc. 35.17 Million USD 1.552%
Caribou Biosciences, Inc. 72.56 Million USD 52.277%
CRISPR Therapeutics AG 346.76 Million USD 90.013%
Precision BioSciences, Inc. 140.92 Million USD 75.425%
Dyadic International, Inc. 2.34 Million USD -1379.546%
Eton Pharmaceuticals, Inc. 16.26 Million USD -112.943%
Fortress Biotech, Inc. 165.93 Million USD 79.13%
Lantern Pharma Inc. 2.73 Million USD -1164.052%
HOOKIPA Pharma Inc. 71.48 Million USD 51.551%
Inhibikase Therapeutics, Inc. 3.52 Million USD -881.403%
Incyte Corporation 1.59 Billion USD 97.825%
IO Biotech, Inc. 17.55 Million USD -97.26%
Jaguar Health, Inc. 45.86 Million USD 24.495%
Novavax, Inc. 2.57 Billion USD 98.654%
Janux Therapeutics, Inc. 36.05 Million USD 3.958%
Opthea Limited 264.6 Million USD 86.912%
Ligand Pharmaceuticals Incorporated 130.7 Million USD 73.505%
ContextLogic Inc. 206 Million USD 83.189%
MiMedx Group, Inc. 96.33 Million USD 64.05%
Pyxis Oncology, Inc. 48.02 Million USD 27.885%
TransCode Therapeutics, Inc. 3.52 Million USD -881.358%
NextCure, Inc. 14.99 Million USD -130.92%
Ocuphire Pharma, Inc. 4.04 Million USD -756.779%
Oncternal Therapeutics, Inc. 6.67 Million USD -418.661%
Outlook Therapeutics, Inc. 46.73 Million USD 25.906%
Vaxcyte, Inc. 167.44 Million USD 79.318%
PDS Biotechnology Corporation 33.25 Million USD -4.125%
Madrigal Pharmaceuticals, Inc. 235.21 Million USD 85.277%
Pharming Group N.V. 244.07 Million USD 85.811%
Pieris Pharmaceuticals, Inc. 11.92 Million USD -190.48%
Avidity Biosciences, Inc. 127.79 Million USD 72.9%
Reviva Pharmaceuticals Holdings, Inc. 6.6 Million USD -424.134%
Reviva Pharmaceuticals Holdings, Inc. 6.6 Million USD -424.134%
Sangamo Therapeutics, Inc. 82.43 Million USD 57.989%
Sol-Gel Technologies Ltd. 6.64 Million USD -421.316%
Acelyrin, Inc. 86.35 Million USD 59.896%
Salarius Pharmaceuticals, Inc. 1.29 Million USD -2565.479%
SELLAS Life Sciences Group, Inc. 14.37 Million USD -140.844%
Summit Therapeutics Inc. 125.25 Million USD 72.352%
Sensei Biotherapeutics, Inc. 9.47 Million USD -265.344%
Senti Biosciences, Inc. 52.57 Million USD 34.125%
Stoke Therapeutics, Inc. 68.77 Million USD 49.647%
Syros Pharmaceuticals, Inc. 151.51 Million USD 77.143%
Alaunos Therapeutics, Inc. 1.95 Million USD -1670.501%
Telomir Pharmaceuticals, Inc. Common Stock 1.33 Million USD -2492.987%
Entrada Therapeutics, Inc. 226.83 Million USD 84.733%
VistaGen Therapeutics, Inc. 9.36 Million USD -269.713%
Wave Life Sciences Ltd. 227.44 Million USD 84.774%
Sorrento Therapeutics, Inc. 494.5 Million USD 92.997%
TRACON Pharmaceuticals, Inc. 10.91 Million USD -217.308%
Barinthus Biotherapeutics plc 27.51 Million USD -25.881%
Psyence Biomedical Ltd. 12.1 Million USD -186.096%
Phathom Pharmaceuticals, Inc. 486.6 Million USD 92.883%
Immix Biopharma, Inc. 3.72 Million USD -830.495%
Keros Therapeutics, Inc. 37.81 Million USD 8.413%
MEI Pharma, Inc. 8.35 Million USD -314.494%
Windtree Therapeutics, Inc. 29.01 Million USD -19.356%
Xeris Biopharma Holdings, Inc. 347.58 Million USD 90.037%
Rigel Pharmaceuticals, Inc. 145.86 Million USD 76.259%
Fortress Biotech, Inc. 165.93 Million USD 79.13%
Precigen, Inc. 41.64 Million USD 16.84%
Clearside Biomedical, Inc. 49.93 Million USD 30.641%
AlloVir, Inc. 45.01 Million USD 23.068%
C4 Therapeutics, Inc. 130.33 Million USD 73.43%
Fate Therapeutics, Inc. 137.8 Million USD 74.869%
ImmuCell Corporation 18.81 Million USD -84.06%
IDEAYA Biosciences, Inc. 28.22 Million USD -22.692%
Onconetix, Inc. 23.18 Million USD -49.395%
PureTech Health plc 125.58 Million USD 72.424%
VYNE Therapeutics Inc. 8.95 Million USD -286.939%
Elevation Oncology, Inc. 34.28 Million USD -1.018%
Kintara Therapeutics, Inc. 2.44 Million USD -1316.401%
Seer, Inc. 39.36 Million USD 12.026%
Verrica Pharmaceuticals Inc. 61.83 Million USD 43.994%
Innoviva, Inc. 568.55 Million USD 93.909%
Aadi Bioscience, Inc. 27.22 Million USD -27.189%
ESSA Pharma Inc. 3.49 Million USD -890.853%
GlycoMimetics, Inc. 6.9 Million USD -401.748%
GT Biopharma, Inc. 6.63 Million USD -422.102%
Inhibrx Biosciences, Inc. 264.39 Million USD 86.902%
Akebia Therapeutics, Inc. 272.28 Million USD 87.281%
Catalyst Pharmaceuticals, Inc. 84.02 Million USD 58.785%
Longboard Pharmaceuticals, Inc. 9.77 Million USD -254.318%
Orchestra BioMed Holdings, Inc. 27.16 Million USD -27.465%
Alzamend Neuro, Inc. 3.22 Million USD -973.572%
Rocket Pharmaceuticals, Inc. 73.76 Million USD 53.054%
Aptose Biosciences Inc. 15.8 Million USD -119.063%
ZyVersa Therapeutics, Inc. 11.03 Million USD -213.696%
Soligenix, Inc. 7.27 Million USD -376.034%
Century Therapeutics, Inc. 175.94 Million USD 80.317%
Kura Oncology, Inc. 51.66 Million USD 32.966%
TScan Therapeutics, Inc. 121.28 Million USD 71.446%
Intensity Therapeutics, Inc. 4.13 Million USD -737.914%
Ocean Biomedical, Inc. 6.61 Million USD -423.613%
CytomX Therapeutics, Inc. 252.59 Million USD 86.29%
Autolus Therapeutics plc 263.9 Million USD 86.878%
Mineralys Therapeutics, Inc. 10.48 Million USD -230.385%
EyePoint Pharmaceuticals, Inc. 88.86 Million USD 61.028%
Eterna Therapeutics Inc. 46.89 Million USD 26.158%
Adaptive Biotechnologies Corporation 352.85 Million USD 90.186%
GRI Bio, Inc. 2.69 Million USD -1184.056%
Xenetic Biosciences, Inc. 809.58 Thousand USD -4177.624%
Tenaya Therapeutics, Inc. 31.09 Million USD -11.386%
IGM Biosciences, Inc. 220.17 Million USD 84.271%
INmune Bio, Inc. 18.86 Million USD -83.602%
Heron Therapeutics, Inc. 256.47 Million USD 86.498%
SAB Biotherapeutics, Inc. 26.64 Million USD -29.987%
Pasithea Therapeutics Corp. 2.71 Million USD -1173.945%
Entero Therapeutics, Inc. 3.28 Million USD -955.738%
Milestone Pharmaceuticals Inc. 58.45 Million USD 40.756%
X4 Pharmaceuticals, Inc. 96.15 Million USD 63.986%
Atara Biotherapeutics, Inc. 264.73 Million USD 86.919%
Coherus BioSciences, Inc. 823.02 Million USD 95.792%
Verastem, Inc. 71.18 Million USD 51.351%
Abeona Therapeutics Inc. 49.17 Million USD 29.577%
Pliant Therapeutics, Inc. 38.57 Million USD 10.231%
Tonix Pharmaceuticals Holding Corp. 48.93 Million USD 29.226%
Histogen Inc. 5.69 Million USD -507.881%
Aprea Therapeutics, Inc. 4.38 Million USD -689.652%
Surrozen, Inc. 8.14 Million USD -325.181%
Organovo Holdings, Inc. 2.74 Million USD -1160.226%
Lixte Biotechnology Holdings, Inc. 313.85 Thousand USD -10933.971%
Ovid Therapeutics Inc. 56.22 Million USD 38.412%
Panbela Therapeutics, Inc. 16.51 Million USD -109.732%
CASI Pharmaceuticals, Inc. 51.1 Million USD 32.233%
Cadrenal Therapeutics, Inc. Common Stock 826.87 Thousand USD -4088.178%
Centessa Pharmaceuticals plc 126.72 Million USD 72.672%
Hepion Pharmaceuticals, Inc. 10.81 Million USD -220.254%
Arcturus Therapeutics Holdings Inc. 150.88 Million USD 77.049%
BioRestorative Therapies, Inc. 2.6 Million USD -1228.209%
Apollomics, Inc. 14.15 Million USD -144.69%
Amarin Corporation plc 279.58 Million USD 87.614%
Mesoblast Limited 188.79 Million USD 81.657%
Turnstone Biologics Corp. 14.14 Million USD -144.777%
Kymera Therapeutics, Inc. 180.78 Million USD 80.844%
Synaptogenix, Inc. 5.52 Million USD -526.299%
Tiziana Life Sciences Ltd 6.64 Million USD -420.924%
Aurinia Pharmaceuticals Inc. 170.1 Million USD 79.642%
BriaCell Therapeutics Corp. 8.55 Million USD -304.7%
Monopar Therapeutics Inc. 1.75 Million USD -1870.589%
Exelixis, Inc. 678.44 Million USD 94.896%
Better Therapeutics, Inc. 23.84 Million USD -45.252%
Nurix Therapeutics, Inc. 164.04 Million USD 78.889%
Apellis Pharmaceuticals, Inc. 594.2 Million USD 94.172%
NLS Pharmaceutics AG 10.68 Million USD -224.254%
Dermata Therapeutics, Inc. 1.62 Million USD -2032.955%
Aridis Pharmaceuticals, Inc. 38.92 Million USD 11.036%
Gritstone bio, Inc. 125.91 Million USD 72.497%
Jasper Therapeutics, Inc. 14.67 Million USD -135.97%
TNF Pharmaceuticals, Inc. 5.08 Million USD -580.557%
Avid Bioservices, Inc. 275.66 Million USD 87.437%
Insmed Incorporated 1.66 Billion USD 97.916%
Virpax Pharmaceuticals, Inc. 7.69 Million USD -350.103%
MediWound Ltd. 27.18 Million USD -27.381%
OmniAb, Inc. 87.4 Million USD 60.376%
Alector, Inc. 487.66 Million USD 92.899%
Seres Therapeutics, Inc. 403.45 Million USD 91.416%
Checkpoint Therapeutics, Inc. 18.42 Million USD -87.957%
Viracta Therapeutics, Inc. 38.37 Million USD 9.752%
Zai Lab Limited 240.17 Million USD 85.581%
Revance Therapeutics, Inc. 630.05 Million USD 94.504%
Aura Biosciences, Inc. 29.22 Million USD -18.49%
Lyell Immunopharma, Inc. 95.07 Million USD 63.576%
Immunic, Inc. 25.36 Million USD -36.515%
Tarsus Pharmaceuticals, Inc. 69.23 Million USD 49.981%
Veracyte, Inc. 93.71 Million USD 63.048%
InMed Pharmaceuticals Inc. 2.61 Million USD -1223.475%
FibroGen, Inc. 585.72 Million USD 94.088%
SeaStar Medical Holding Corporation 17.38 Million USD -99.223%
Adial Pharmaceuticals, Inc. 653.07 Thousand USD -5202.752%
Sonnet BioTherapeutics Holdings, Inc. 5.65 Million USD -512.347%
Jazz Pharmaceuticals plc 7.65 Billion USD 99.548%
Cyclacel Pharmaceuticals, Inc. 8.19 Million USD -322.432%
Amylyx Pharmaceuticals, Inc. 84.02 Million USD 58.783%
TG Therapeutics, Inc. 169.08 Million USD 79.519%
Galecto, Inc. 5.89 Million USD -487.364%
Calithera Biosciences, Inc. 8.28 Million USD -318.047%
Fortrea Holdings Inc. 2.61 Billion USD 98.677%
KalVista Pharmaceuticals, Inc. 28.82 Million USD -20.155%
Aptevo Therapeutics Inc. 12.62 Million USD -174.392%
XBiotech Inc. 8.39 Million USD -312.421%
Jasper Therapeutics, Inc. 14.67 Million USD -135.97%
Lyra Therapeutics, Inc. 53.18 Million USD 34.88%
Foghorn Therapeutics Inc. 363.1 Million USD 90.463%
Y-mAbs Therapeutics, Inc. 26.88 Million USD -28.816%
Theravance Biopharma, Inc. 169 Million USD 79.509%
Ultragenyx Pharmaceutical Inc. 1.21 Billion USD 97.151%
Metagenomi, Inc. Common Stock 500.42 Million USD 93.08%
Vaxxinity, Inc. 30.94 Million USD -11.915%
BioCryst Pharmaceuticals, Inc. 972.48 Million USD 96.439%
Gain Therapeutics, Inc. 6.03 Million USD -474.206%
Cartesian Therapeutics, Inc. 745.23 Million USD 95.353%
NexImmune, Inc. 5.08 Million USD -581.145%
Creative Medical Technology Holdings, Inc. 371.39 Thousand USD -9224.599%
Marker Therapeutics, Inc. 3.07 Million USD -1026.267%
Regeneron Pharmaceuticals, Inc. 7.1 Billion USD 99.513%
Chemomab Therapeutics Ltd. 5.15 Million USD -571.921%
Scopus BioPharma Inc. 7.45 Million USD -364.569%
RAPT Therapeutics, Inc. 26.29 Million USD -31.707%
Ainos, Inc. 7.39 Million USD -368.352%
Pluri Inc. 34.11 Million USD -1.521%
Prothena Corporation plc 135.01 Million USD 74.351%
Adaptimmune Therapeutics plc 243.1 Million USD 85.755%
Celularity Inc. 102.92 Million USD 66.354%
Rallybio Corporation 9.43 Million USD -267.009%
Cue Biopharma, Inc. 24.44 Million USD -41.669%
MeiraGTx Holdings plc 319.99 Million USD 89.178%
Omeros Corporation 403.25 Million USD 91.412%
Humacyte, Inc. 114.67 Million USD 69.801%
Immunocore Holdings plc 228.15 Million USD 84.821%
Cocrystal Pharma, Inc. 4.87 Million USD -610.379%
Cidara Therapeutics, Inc. 76.74 Million USD 54.872%
Blueprint Medicines Corporation 918.64 Million USD 96.23%
CalciMedica, Inc. 4.02 Million USD -759.757%
Cabaletta Bio, Inc. 17.45 Million USD -98.436%
Marinus Pharmaceuticals, Inc. 154.14 Million USD 77.533%
Scholar Rock Holding Corporation 85.81 Million USD 59.646%
Sana Biotechnology, Inc. 277.79 Million USD 87.534%
Pulmatrix, Inc. 15.96 Million USD -116.945%
Elicio Therapeutics, Inc. 15.77 Million USD -119.559%
Vigil Neuroscience, Inc. 24.6 Million USD -40.742%
Intellia Therapeutics, Inc. 250.8 Million USD 86.192%
Adlai Nortye Ltd. American Depositary Shares 50.78 Million USD 31.81%
Cytokinetics, Incorporated 1.21 Billion USD 97.139%
Eloxx Pharmaceuticals, Inc. 31.78 Million USD -8.961%
Nutriband Inc. 1.07 Million USD -3109.787%
Protara Therapeutics, Inc. 10.63 Million USD -225.694%
Vor Biopharma Inc. 59.1 Million USD 41.407%
Roivant Sciences Ltd. 773.95 Million USD 95.525%
Evogene Ltd. 17.99 Million USD -92.501%
ProKidney Corp. 29.21 Million USD -18.534%
Applied Therapeutics, Inc. 71.97 Million USD 51.887%
Hoth Therapeutics, Inc. 704.98 Thousand USD -4812.317%
BridgeBio Pharma, Inc. 1.88 Billion USD 98.167%
CorMedix Inc. 11.91 Million USD -190.589%
BioLineRx Ltd. 50.7 Million USD 31.697%
Tango Therapeutics, Inc. 149.45 Million USD 76.829%
Galectin Therapeutics Inc. 88.44 Million USD 60.843%
Atai Life Sciences N.V. 49.16 Million USD 29.557%
Renovaro Biosciences Inc. 31.15 Million USD -11.167%
Aerovate Therapeutics, Inc. 17.96 Million USD -92.801%
Zentalis Pharmaceuticals, Inc. 124.63 Million USD 72.214%
Sagimet Biosciences Inc. 5.65 Million USD -512.504%
MediciNova, Inc. 3.89 Million USD -789.902%
Praxis Precision Medicines, Inc. 18.27 Million USD -89.458%
Cardio Diagnostics Holdings, Inc. 1.5 Million USD -2202.224%
GeoVax Labs, Inc. 3.51 Million USD -883.868%
Axsome Therapeutics, Inc. 397.25 Million USD 91.283%
Biomea Fusion, Inc. 30.69 Million USD -12.841%
PTC Therapeutics, Inc. 2.72 Billion USD 98.728%
Mereo BioPharma Group plc 15.96 Million USD -116.959%
Cullinan Oncology, Inc. 31.2 Million USD -10.993%
Syndax Pharmaceuticals, Inc. 58.68 Million USD 40.987%
Absci Corporation 58.3 Million USD 40.603%
NRx Pharmaceuticals, Inc. 19.04 Million USD -81.809%
4D Molecular Therapeutics, Inc. 32.06 Million USD -8.013%
Dyne Therapeutics, Inc. 73.79 Million USD 53.068%
Kiniksa Pharmaceuticals, Ltd. 87.48 Million USD 60.414%
Ventyx Biosciences, Inc. 33.77 Million USD -2.55%
Allakos Inc. 74.79 Million USD 53.698%
Imunon, Inc. 8.53 Million USD -305.97%
Fulcrum Therapeutics, Inc. 22.5 Million USD -53.909%
Corcept Therapeutics Incorporated 114.81 Million USD 69.837%
BioAtla, Inc. 48.98 Million USD 29.304%
NLS Pharmaceutics AG 10.68 Million USD -224.254%
Bio-Path Holdings, Inc. 2.77 Million USD -1146.168%
Allogene Therapeutics, Inc. 130.6 Million USD 73.484%
Larimar Therapeutics, Inc. 14.21 Million USD -143.623%
XOMA Corporation 145.58 Million USD 76.212%
Kezar Life Sciences, Inc. 33.66 Million USD -2.869%
Cara Therapeutics, Inc. 68.75 Million USD 49.634%
aTyr Pharma, Inc. 31.59 Million USD -9.602%
Aligos Therapeutics, Inc. 61.82 Million USD 43.984%
Akero Therapeutics, Inc. 44.96 Million USD 22.982%
Viridian Therapeutics, Inc. 48.4 Million USD 28.451%
Eliem Therapeutics, Inc. 2.87 Million USD -1106.655%
EyeGate Pharmaceuticals, Inc. 8.15 Million USD -324.503%
Akari Therapeutics, Plc 4.58 Million USD -655.476%
Tevogen Bio Holdings Inc. 17.73 Million USD -95.29%
Halozyme Therapeutics, Inc. 1.64 Billion USD 97.9%
Lexaria Bioscience Corp. 403.9 Thousand USD -8473.982%
UroGen Pharma Ltd. 243.52 Million USD 85.779%
Sutro Biopharma, Inc. 321.08 Million USD 89.214%
ZIVO Bioscience, Inc. 2.76 Million USD -1154.038%
Orgenesis Inc. 35.53 Million USD 2.544%
Entera Bio Ltd. 1.37 Million USD -2411.313%
GH Research PLC 6.7 Million USD -416.803%
Lisata Therapeutics, Inc. 6.8 Million USD -409.279%
Reneo Pharmaceuticals, Inc. 18.82 Million USD -83.953%
Xencor, Inc. 283.55 Million USD 87.787%
60 Degrees Pharmaceuticals, Inc. 2.98 Million USD -1059.905%
Replimune Group, Inc. 113.21 Million USD 69.411%
Coeptis Therapeutics Holdings, Inc. 3.75 Million USD -821.742%
Vanda Pharmaceuticals Inc. 103.53 Million USD 66.55%
Lexaria Bioscience Corp. 403.9 Thousand USD -8473.982%
Portage Biotech Inc. 4.45 Million USD -678.225%
Cardio Diagnostics Holdings, Inc. 1.5 Million USD -2202.224%
Olema Pharmaceuticals, Inc. 23.05 Million USD -50.243%
OncoCyte Corporation 49.29 Million USD 29.752%
Qualigen Therapeutics, Inc. 4.13 Million USD -737.144%
Processa Pharmaceuticals, Inc. 797.48 Thousand USD -4242.532%
Purple Biotech Ltd. 10 Million USD -246.137%
CollPlant Biotechnologies Ltd. 5.78 Million USD -498.531%
scPharmaceuticals Inc. 57.26 Million USD 39.521%
ProMIS Neurosciences, Inc. 12.38 Million USD -179.552%
HilleVax, Inc. 78.9 Million USD 56.113%
NeuroSense Therapeutics Ltd. 5.05 Million USD -585.762%
Tharimmune, Inc. 1.81 Million USD -1807.996%
Genprex, Inc. 3.25 Million USD -964.191%
Neumora Therapeutics, Inc. Common Stock 27.11 Million USD -27.7%
Atossa Therapeutics, Inc. 5.23 Million USD -561.402%
XTL Biopharmaceuticals Ltd. 206 Thousand USD -16711.165%
Virios Therapeutics, Inc. 358.54 Thousand USD -9558.679%
OKYO Pharma Limited 7.42 Million USD -366.672%
Savara Inc. 37.19 Million USD 6.886%
Curis, Inc. 57.61 Million USD 39.889%
Daré Bioscience, Inc. 26.32 Million USD -31.527%
Carmell Therapeutics Corporation 39.19 Million USD 11.655%
Titan Pharmaceuticals, Inc. 1.44 Million USD -2298.269%
Achieve Life Sciences, Inc. 20.81 Million USD -66.343%
BeiGene, Ltd. 2.23 Billion USD 98.45%
Kiromic BioPharma, Inc. 21.28 Million USD -62.665%
Revolution Medicines, Inc. Warrant 262.39 Million USD 86.802%
Protagonist Therapeutics, Inc. 21.27 Million USD -62.786%
Erasca, Inc. 78.61 Million USD 55.946%
bluebird bio, Inc. 424.62 Million USD 91.844%
Protagenic Therapeutics, Inc. 655.25 Thousand USD -5185.142%
BioMarin Pharmaceutical Inc. 1.89 Billion USD 98.168%
DBV Technologies S.A. 42.8 Million USD 19.086%
Protagenic Therapeutics, Inc. 655.25 Thousand USD -5185.142%
Moderna, Inc. 4.57 Billion USD 99.243%
Vincerx Pharma, Inc. 6.99 Million USD -395.082%
Fresh Tracks Therapeutics, Inc. 1.65 Million USD -1991.244%
Molecular Templates, Inc. 31.17 Million USD -11.1%
Acrivon Therapeutics, Inc. Common Stock 17.07 Million USD -102.876%
Travere Therapeutics, Inc. 588.1 Million USD 94.111%
Monte Rosa Therapeutics, Inc. 124.5 Million USD 72.185%
Spruce Biosciences, Inc. 27.43 Million USD -26.22%
Celldex Therapeutics, Inc. 36.45 Million USD 5.006%
Cogent Biosciences, Inc. 55.63 Million USD 37.753%
MacroGenics, Inc. 154.2 Million USD 77.543%
RenovoRx, Inc. 4.46 Million USD -675.437%
Adicet Bio, Inc. 37.12 Million USD 6.705%
Prime Medicine, Inc. 60.78 Million USD 43.022%
Aditxt, Inc. 28.53 Million USD -21.378%
Adagene Inc. 45.16 Million USD 23.331%
Estrella Immunopharma, Inc. 180.7 Thousand USD -19064.808%
Quantum-Si incorporated 26.63 Million USD -30.04%
Maravai LifeSciences Holdings, Inc. 697.56 Million USD 95.035%
Acurx Pharmaceuticals, Inc. 3.04 Million USD -1038.265%
Voyager Therapeutics, Inc. 114.96 Million USD 69.876%
SciSparc Ltd. 1.59 Million USD -2071.223%
Vericel Corporation 127.7 Million USD 72.882%
Revelation Biosciences, Inc. 5.56 Million USD -522.312%
Minerva Neurosciences, Inc. 85.35 Million USD 59.429%
Generation Bio Co. 171.63 Million USD 79.822%
Astria Therapeutics, Inc. 11.55 Million USD -199.835%
Black Diamond Therapeutics, Inc. 41.83 Million USD 17.212%
Arcutis Biotherapeutics, Inc. 252.69 Million USD 86.295%
Invivyd, Inc. 51.71 Million USD 33.032%
Relay Therapeutics, Inc. 91.97 Million USD 62.348%
Quoin Pharmaceuticals, Ltd. 6.5 Million USD -432.355%
Spero Therapeutics, Inc. 75.49 Million USD 54.129%
Artelo Biosciences, Inc. 1.02 Million USD -3291.871%
2seventy bio, Inc. 310.12 Million USD 88.833%
ADMA Biologics, Inc. 193.97 Million USD 82.147%
Clene Inc. 38.95 Million USD 11.091%
Capricor Therapeutics, Inc. 36.13 Million USD 4.156%
Boundless Bio, Inc. Common Stock 256.97 Million USD 86.524%
GeoVax Labs, Inc. 3.51 Million USD -883.868%
Recursion Pharmaceuticals, Inc. 190.26 Million USD 81.798%
Citius Pharmaceuticals, Inc. 12.17 Million USD -184.335%
Contineum Therapeutics, Inc. Class A Common Stock 198.32 Million USD 82.538%
Relmada Therapeutics, Inc. 12.19 Million USD -183.982%
Finch Therapeutics Group, Inc. 48.11 Million USD 28.019%
ALX Oncology Holdings Inc. 52.84 Million USD 34.462%
Vir Biotechnology, Inc. 369.85 Million USD 90.637%
Evaxion Biotech A/S 17.61 Million USD -96.572%
Ocular Therapeutix, Inc. 160.92 Million USD 78.481%
Verve Therapeutics, Inc. 153.18 Million USD 77.393%
Trevena, Inc. 48.26 Million USD 28.244%
Surrozen, Inc. 8.14 Million USD -325.181%
Tyra Biosciences, Inc. 21.59 Million USD -60.366%
Cingulate Inc. 10.36 Million USD -234.248%
Galmed Pharmaceuticals Ltd. 2.75 Million USD -1159.309%
Unity Biotechnology, Inc. 37.29 Million USD 7.136%
Tenax Therapeutics, Inc. 3.58 Million USD -865.588%
Terns Pharmaceuticals, Inc. 13.15 Million USD -163.354%
ACADIA Pharmaceuticals Inc. 317.2 Million USD 89.082%
Connect Biopharma Holdings Limited 24.84 Million USD -39.366%
Clearmind Medicine Inc. 3.61 Million USD -859.305%
Kronos Bio, Inc. 54.2 Million USD 36.106%
Bolt Biotherapeutics, Inc. 47.04 Million USD 26.384%
CERo Therapeutics Holdings, Inc. 22.75 Million USD -52.159%
Viking Therapeutics, Inc. 20.07 Million USD -72.542%
Statera Biopharma, Inc. 22.67 Million USD -52.718%
ImmunityBio, Inc. 1.09 Billion USD 96.824%
Korro Bio, Inc. 51.75 Million USD 33.083%
Kineta, Inc. 7.22 Million USD -379.521%
BioVie Inc. 9.7 Million USD -256.942%
Codexis, Inc. 49.94 Million USD 30.663%
Celularity Inc. 102.92 Million USD 66.354%
Crinetics Pharmaceuticals, Inc. 96.24 Million USD 64.019%
Celcuity Inc. 51.45 Million USD 32.69%
Virax Biolabs Group Limited 345.19 Thousand USD -9932.33%
Cibus, Inc. 206.11 Million USD 83.198%
Eledon Pharmaceuticals, Inc. 42.47 Million USD 18.467%
eFFECTOR Therapeutics, Inc. 26.33 Million USD -31.482%
IN8bio, Inc. 8.77 Million USD -294.79%
Kodiak Sciences Inc. 213.59 Million USD 83.786%
Annexon, Inc. 47.11 Million USD 26.502%
Adverum Biotechnologies, Inc. 89.54 Million USD 61.324%
Assembly Biosciences, Inc. 96.37 Million USD 64.065%
Avalo Therapeutics, Inc. 13.68 Million USD -152.984%
Ionis Pharmaceuticals, Inc. 2.6 Billion USD 98.67%
Eyenovia, Inc. 19.78 Million USD -75.078%
Puma Biotechnology, Inc. 177.08 Million USD 80.444%
Conduit Pharmaceuticals Inc. 7.68 Million USD -350.866%
Xilio Therapeutics, Inc. 24.09 Million USD -43.703%
Arcellx, Inc. 339.75 Million USD 89.807%
Cardiff Oncology, Inc. 11.89 Million USD -191.066%
Enanta Pharmaceuticals, Inc. 245.54 Million USD 85.896%
Regulus Therapeutics Inc. 9.56 Million USD -262.135%
Moolec Science SA 13.94 Million USD -148.334%
Acumen Pharmaceuticals, Inc. 43.15 Million USD 19.746%
Geron Corporation 146.12 Million USD 76.301%
LAVA Therapeutics N.V. 50.53 Million USD 31.467%
Royalty Pharma plc 6.29 Billion USD 99.45%
Atea Pharmaceuticals, Inc. 39.77 Million USD 12.935%
Greenwich LifeSciences, Inc. 294.4 Thousand USD -11663.008%
TFF Pharmaceuticals, Inc. 2.46 Million USD -1307.603%
Mersana Therapeutics, Inc. 189.15 Million USD 81.692%
Humacyte, Inc. 114.67 Million USD 69.801%
Structure Therapeutics Inc. 29.05 Million USD -19.208%
89bio, Inc. 59.96 Million USD 42.246%
PMV Pharmaceuticals, Inc. 26.46 Million USD -30.866%
Avenue Therapeutics, Inc. 1.19 Million USD -2795.569%
Genelux Corporation 8.42 Million USD -311.295%
Trevi Therapeutics, Inc. 6.85 Million USD -405.12%
Lexicon Pharmaceuticals, Inc. 136.31 Million USD 74.596%
Notable Labs, Ltd. 4.42 Million USD -682.268%
Liquidia Corporation 73.13 Million USD 52.65%
Mustang Bio, Inc. 17.61 Million USD -96.555%
Immunovant, Inc. 48.95 Million USD 29.26%
Quantum-Si incorporated 26.63 Million USD -30.04%
Arbutus Biopharma Corporation 38.38 Million USD 9.775%
DiaMedica Therapeutics Inc. 3.1 Million USD -1016.049%
Vera Therapeutics, Inc. 73.86 Million USD 53.113%
Acasti Pharma Inc. 11.55 Million USD -199.654%
MiNK Therapeutics, Inc. 22.6 Million USD -53.182%
Pasithea Therapeutics Corp. 2.71 Million USD -1173.945%
Xenon Pharmaceuticals Inc. 36.87 Million USD 6.091%
Elevai Labs, Inc. Common Stock 1.36 Million USD -2441.087%
NeuroBo Pharmaceuticals, Inc. 6.09 Million USD -468.094%
Tempest Therapeutics, Inc. 24.83 Million USD -39.444%
Soleno Therapeutics, Inc. 23.18 Million USD -49.375%
Moleculin Biotech, Inc. 12.14 Million USD -185.17%
United Therapeutics Corporation 1.18 Billion USD 97.071%
Nuvectis Pharma, Inc. 6.98 Million USD -395.862%
Solid Biosciences Inc. 38.45 Million USD 9.951%
BriaCell Therapeutics Corp. 8.55 Million USD -304.7%
Immuneering Corporation 12 Million USD -188.391%
Lixte Biotechnology Holdings, Inc. 313.85 Thousand USD -10933.971%
Silo Pharma, Inc. 1.56 Million USD -2106.822%
Belite Bio, Inc 4.21 Million USD -722.394%
XOMA Corporation 145.58 Million USD 76.212%
ARS Pharmaceuticals, Inc. 2.42 Million USD -1326.318%
Bionomics Limited 10.15 Million USD -240.899%
Apogee Therapeutics, Inc. 21.49 Million USD -61.142%
Alpha Tau Medical Ltd. 22.91 Million USD -51.141%
uniQure N.V. 624.01 Million USD 94.45%
Cassava Sciences, Inc. 14.19 Million USD -143.966%
Estrella Immunopharma, Inc. 180.7 Thousand USD -19064.808%
Poseida Therapeutics, Inc. 170.18 Million USD 79.651%
Forte Biosciences, Inc. 3.66 Million USD -844.654%
Anebulo Pharmaceuticals, Inc. 260.58 Thousand USD -13189.816%
Enlivex Therapeutics Ltd. 6.74 Million USD -413.28%
Conduit Pharmaceuticals Inc. 7.68 Million USD -350.866%
SeaStar Medical Holding Corporation 17.38 Million USD -99.223%
FibroBiologics, Inc. Common Stock 10.56 Million USD -227.697%
Altimmune, Inc. 16.54 Million USD -109.365%
Amicus Therapeutics, Inc. 617.7 Million USD 94.394%
Alpha Tau Medical Ltd. 22.91 Million USD -51.141%
Compugen Ltd. 55.77 Million USD 37.909%
Peak Bio, Inc. 20.75 Million USD -66.869%
Zevra Therapeutics, Inc. 110.46 Million USD 68.649%
Benitec Biopharma Inc. 4.96 Million USD -597.924%
Spyre Therapeutics, Inc. 157.84 Million USD 78.06%
NKGen Biotech, Inc. Common Stock 75.17 Million USD 53.932%
Zura Bio Limited 21.29 Million USD -62.648%
PolyPid Ltd. 17.46 Million USD -98.254%
Aileron Therapeutics, Inc. 112.39 Million USD 69.189%
NKGen Biotech, Inc. Warrants 75.17 Million USD 53.932%
Instil Bio, Inc. 99.8 Million USD 65.3%
argenx SE 444.95 Million USD 92.217%
Immunome, Inc. 28.65 Million USD -20.842%
Compass Therapeutics, Inc. 8.33 Million USD -315.389%
Verona Pharma plc 58.84 Million USD 41.145%
enGene Holdings Inc. Warrants 14.47 Million USD -139.28%
Shattuck Labs, Inc. 14.85 Million USD -133.064%
CervoMed Inc. 2.59 Million USD -1234.144%
LENZ Therapeutics, Inc. 4.87 Million USD -610.525%
Plus Therapeutics, Inc. 12.73 Million USD -171.914%
Dianthus Therapeutics, Inc. 10.53 Million USD -228.723%
Moolec Science SA 13.94 Million USD -148.334%
Enveric Biosciences, Inc. 2.34 Million USD -1377.744%
Inovio Pharmaceuticals, Inc. 55.59 Million USD 37.709%
AnaptysBio, Inc. 364.28 Million USD 90.493%
Design Therapeutics, Inc. 11.95 Million USD -189.654%
Leap Therapeutics, Inc. 12.68 Million USD -173.029%
NeurAxis, Inc. 1.91 Million USD -1710.545%
Seelos Therapeutics, Inc. 38.92 Million USD 11.038%
Lumos Pharma, Inc. 13.33 Million USD -159.739%
Achilles Therapeutics plc 19.08 Million USD -81.438%
enGene Holdings Inc. Common Stock 14.47 Million USD -139.28%
180 Life Sciences Corp. 5.38 Million USD -542.838%
Opiant Pharmaceuticals, Inc. 23.58 Million USD -46.816%
CERo Therapeutics Holdings, Inc. 22.75 Million USD -52.159%
Nutriband Inc. 1.07 Million USD -3109.787%
ORIC Pharmaceuticals, Inc. 30.59 Million USD -13.181%
CG Oncology, Inc. Common stock 14.51 Million USD -138.653%
Fractyl Health, Inc. Common Stock 401.27 Million USD 91.37%
Rani Therapeutics Holdings, Inc. 32.47 Million USD -6.646%
MoonLake Immunotherapeutics 13.04 Million USD -165.39%
Palisade Bio, Inc. 2.73 Million USD -1164.367%
Tourmaline Bio, Inc. 5.25 Million USD -559.261%
Beam Therapeutics Inc. 478.38 Million USD 92.761%
Neurogene Inc. 36.54 Million USD 5.248%
Mirum Pharmaceuticals, Inc. 397.95 Million USD 91.298%
AEON Biopharma, Inc. 159.88 Million USD 78.341%
CARGO Therapeutics, Inc. Common Stock 47.65 Million USD 27.322%
Sesen Bio, Inc. 30.98 Million USD -11.771%
Enliven Therapeutics, Inc. 25.96 Million USD -33.396%
Kiora Pharmaceuticals, Inc. 7.6 Million USD -355.538%
Iovance Biotherapeutics, Inc. 195.73 Million USD 82.307%
Taysha Gene Therapies, Inc. 192.05 Million USD 81.968%
Athira Pharma, Inc. 30.05 Million USD -15.218%
Vaccinex, Inc. 5.94 Million USD -482.817%
HCW Biologics Inc. 15.05 Million USD -130.077%
XOMA Corporation 145.58 Million USD 76.212%
Nektar Therapeutics 267.04 Million USD 87.032%
Arvinas, Inc. 644.6 Million USD 94.628%
Tevogen Bio Holdings Inc. 17.73 Million USD -95.29%
Merus N.V. 102.15 Million USD 66.098%
Omega Therapeutics, Inc. 146.35 Million USD 76.337%
Quince Therapeutics, Inc. 95.12 Million USD 63.592%
Rezolute, Inc. 11.73 Million USD -195.134%
Clene Inc. 38.95 Million USD 11.091%
Indaptus Therapeutics, Inc. 2.84 Million USD -1116.241%
BeyondSpring Inc. 48.26 Million USD 28.254%
Synlogic, Inc. 32.89 Million USD -5.277%
Allarity Therapeutics, Inc. 14.61 Million USD -136.988%
Phio Pharmaceuticals Corp. 1.63 Million USD -2019.4%
Peak Bio, Inc. 20.75 Million USD -66.869%
Werewolf Therapeutics, Inc. 63.45 Million USD 45.428%
Krystal Biotech, Inc. 39.71 Million USD 12.799%
Karyopharm Therapeutics Inc. 376.64 Million USD 90.805%
SpringWorks Therapeutics, Inc. 99.56 Million USD 65.219%
Lipella Pharmaceuticals Inc. 432.72 Thousand USD -7902.986%
MannKind Corporation 721.36 Million USD 95.199%
Ikena Oncology, Inc. 22.33 Million USD -55.053%
Cyclerion Therapeutics, Inc. 2.08 Million USD -1560.163%
Gyre Therapeutics, Inc. 102.59 Million USD 66.243%
Gossamer Bio, Inc. 249.14 Million USD 86.1%
CohBar, Inc. 1.03 Million USD -3250.399%
Cognition Therapeutics, Inc. 10.68 Million USD -223.987%
NRx Pharmaceuticals, Inc. 19.04 Million USD -81.809%
Legend Biotech Corporation 589.93 Million USD 94.13%
Mural Oncology plc 37.92 Million USD 8.693%
Biora Therapeutics, Inc. 132.63 Million USD 73.89%
PaxMedica, Inc. Common Stock 2.29 Million USD -1408.758%
Disc Medicine, Inc. 22.87 Million USD -51.392%
Champions Oncology, Inc. 28.03 Million USD -23.528%
REGENXBIO Inc. 262.22 Million USD 86.794%
Ensysce Biosciences, Inc. 3.35 Million USD -930.883%
Anavex Life Sciences Corp. 12.53 Million USD -176.296%
Cellectar Biosciences, Inc. 13.43 Million USD -157.832%
Edgewise Therapeutics, Inc. 21.2 Million USD -63.315%
Vaxart, Inc. 34.02 Million USD -1.781%
PharmaCyte Biotech, Inc. 20.38 Million USD -69.849%
Aldeyra Therapeutics, Inc. 28.53 Million USD -21.377%
Cellectis S.A. 249.57 Million USD 86.124%
Longeveron Inc. 5.33 Million USD -548.885%
Repare Therapeutics Inc. 41.81 Million USD 17.188%
Sarepta Therapeutics, Inc. 2.4 Billion USD 98.56%
Inozyme Pharma, Inc. 60.36 Million USD 42.634%
Revolution Medicines, Inc. 262.39 Million USD 86.802%
Nymox Pharmaceutical Corporation 2.1 Million USD -1543.617%
Third Harmonic Bio, Inc. 8.62 Million USD -301.472%
ArriVent BioPharma, Inc. Common Stock 11.8 Million USD -193.458%
AN2 Therapeutics, Inc. 14.04 Million USD -146.607%
Anixa Biosciences, Inc. 2.15 Million USD -1509.995%
Vertex Pharmaceuticals Incorporated 5.14 Billion USD 99.328%
Denali Therapeutics Inc. 122.96 Million USD 71.836%
Revelation Biosciences, Inc. 5.56 Million USD -522.312%
Veru Inc. 32.81 Million USD -5.541%
Corvus Pharmaceuticals, Inc. 6.86 Million USD -404.164%
Cingulate Inc. 10.36 Million USD -234.248%
Passage Bio, Inc. 39.26 Million USD 11.795%
Context Therapeutics Inc. 4.19 Million USD -726.177%
Exicure, Inc. 8.54 Million USD -305.088%
Day One Biopharmaceuticals, Inc. 29.5 Million USD -17.361%
Oramed Pharmaceuticals Inc. 10.48 Million USD -230.259%
Scinai Immunotherapeutics Ltd. 22.04 Million USD -57.121%
Rhythm Pharmaceuticals, Inc. 162.98 Million USD 78.752%
Nuvalent, Inc. 31.82 Million USD -8.824%
ABVC BioPharma, Inc. 6.36 Million USD -444.373%
Carisma Therapeutics, Inc. 63.02 Million USD 45.049%
Unicycive Therapeutics, Inc. 18 Million USD -92.394%
OmniAb, Inc. 87.4 Million USD 60.376%
Anew Medical, Inc. 8.24 Million USD -320.187%
Fennec Pharmaceuticals Inc. 38.28 Million USD 9.554%
Lipocine Inc. 2.63 Million USD -1215.953%
Lexeo Therapeutics, Inc. Common Stock 26.27 Million USD -31.817%
Nautilus Biotechnology, Inc. 40.21 Million USD 13.879%
SAB Biotherapeutics, Inc. 26.64 Million USD -29.987%
G1 Therapeutics, Inc. 86.15 Million USD 59.803%
Bellerophon Therapeutics, Inc. 5.4 Million USD -541.196%
Sage Therapeutics, Inc. 82.74 Million USD 58.148%
Ocugen, Inc. 23.98 Million USD -44.398%
Mind Medicine (MindMed) Inc. 46.4 Million USD 25.375%
Q32 Bio Inc. 233.12 Million USD 85.145%
Brainstorm Cell Therapeutics Inc. 9.06 Million USD -281.988%
Alumis Inc. Common Stock 53.5 Million USD 35.272%
Equillium, Inc. 27.95 Million USD -23.872%
Kyverna Therapeutics, Inc. 206.59 Million USD 83.237%
Coya Therapeutics, Inc. 5.62 Million USD -515.48%
CNS Pharmaceuticals, Inc. 6.13 Million USD -464.67%
Galera Therapeutics, Inc. 157.32 Million USD 77.988%
Evelo Biosciences, Inc. 69.43 Million USD 50.123%
Comera Life Sciences Holdings, Inc. 9.97 Million USD -247.206%
Dominari Holdings Inc. 4.63 Million USD -647.163%
Edesa Biotech, Inc. 1.84 Million USD -1780.447%
vTv Therapeutics Inc. 29.56 Million USD -17.127%
Bio-Techne Corporation 744.34 Million USD 95.347%
Agios Pharmaceuticals, Inc. 126.09 Million USD 72.537%
Harmony Biosciences Holdings, Inc. 344.45 Million USD 89.946%
Prelude Therapeutics Incorporated 40.57 Million USD 14.649%
Candel Therapeutics, Inc. 28.95 Million USD -19.595%
iTeos Therapeutics, Inc. 92.36 Million USD 62.504%
Nkarta, Inc. 105.6 Million USD 67.205%
BioCardia, Inc. 4.59 Million USD -654.488%
Iterum Therapeutics plc 32.66 Million USD -6.028%